[PDF][PDF] The management of pulmonary fibrosis in COVID-19
CM Rumende, EC Susanto, TP Sitorus - Acta Med Indones, 2021 - academia.edu
Pulmonary fibrosis due to COVID-19 is recognized as sequel of ARDS characterized by
failed alveolar reepithelization, fibroblast activation, excessive collagen deposition and other …
failed alveolar reepithelization, fibroblast activation, excessive collagen deposition and other …
Pulmonary fibrosis caused by severe COVID-19 infection: discharge may not be the end of treatment
CM Rumende - Acta Medica Indonesiana, 2021 - actamedindones.org
Abstract Since December 2019, COVID-19 caused by SARS-CoV-2 infection has been
spread rapidly in the world. Beside acute respiratory distress syndrome found in acute …
spread rapidly in the world. Beside acute respiratory distress syndrome found in acute …
Nintedanib in the management of pulmonary fibrosis after COVID-19: a case report
R Chakrabortty, S Rahman, R Jahan, AH Dip… - BIRDEM Medical …, 2021 - banglajol.info
Pulmonary fibrosis is becoming a recognized complication of coronavirus disease 2019
(COVID-19). Patients with pulmonary fibrosis may present with dry cough, shortness of …
(COVID-19). Patients with pulmonary fibrosis may present with dry cough, shortness of …
[PDF][PDF] Post Covid-19 pulmonary fibrosis: A review article
D Patel, P Patel, N Raval, J Kakadiya - 2022 - researchgate.net
COVID-19 also known as Coronavirus disease 2019 is an infectious disease caused by the
highly contagious pathogen SARS-CoV-2. Various studies have found that 70–80% of …
highly contagious pathogen SARS-CoV-2. Various studies have found that 70–80% of …